HMG-CoA reductase inhibitors and bile lithogenicity: cholesterol supersaturation or nucleation defect?

Eur J Gastroenterol Hepatol. 1996 Mar;8(3):195-6. doi: 10.1097/00042737-199603000-00001.
No abstract available

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology
  • Bile / chemistry
  • Bile / drug effects
  • Bile / physiology*
  • Cholelithiasis / enzymology
  • Cholelithiasis / etiology*
  • Cholelithiasis / prevention & control
  • Cholesterol / chemistry
  • Cholesterol / physiology*
  • Crystallization
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*

Substances

  • Anticholesteremic Agents
  • Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol